PMDA — authorised 30 March 2017
- Marketing authorisation holder: Takeda Pharmaceutical Company Limited
- Status: approved
🇯🇵 Ninlaro in Japan
PMDA authorised Ninlaro on 30 March 2017
Marketing authorisation
Ninlaro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Ninlaro approved in Japan?
Yes. PMDA authorised it on 30 March 2017.
Who is the marketing authorisation holder for Ninlaro in Japan?
Takeda Pharmaceutical Company Limited holds the Japanese marketing authorisation.